121 related articles for article (PubMed ID: 11574673)
1. Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter.
Ogbourne SM; Antalis TM
Nucleic Acids Res; 2001 Oct; 29(19):3919-27. PubMed ID: 11574673
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: localization of an upstream transcriptional silencer.
Antalis TM; Costelloe E; Muddiman J; Ogbourne S; Donnan K
Blood; 1996 Nov; 88(10):3686-97. PubMed ID: 8916932
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator.
Stringer B; Udofa EA; Antalis TM
J Biol Chem; 2012 Mar; 287(13):10579-10589. PubMed ID: 22334683
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif.
Mahony D; Kalionis B; Antalis TM
Eur J Biochem; 1999 Aug; 263(3):765-72. PubMed ID: 10469140
[TBL] [Abstract][Full Text] [Related]
5. An AU-rich sequence in the 3'-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR.
Maurer F; Tierney M; Medcalf RL
Nucleic Acids Res; 1999 Apr; 27(7):1664-73. PubMed ID: 10075998
[TBL] [Abstract][Full Text] [Related]
6. Growth state-dependent binding of USF-1 to a proximal promoter E box element in the rat plasminogen activator inhibitor type 1 gene.
White LA; Bruzdzinski C; Kutz SM; Gelehrter TD; Higgins PJ
Exp Cell Res; 2000 Oct; 260(1):127-35. PubMed ID: 11010817
[TBL] [Abstract][Full Text] [Related]
7. Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2.
Antalis TM; Godbolt D; Donnan KD; Stringer BW
Gene; 1993 Dec; 134(2):201-8. PubMed ID: 8262378
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
9. NF1 regulatory element functions as a repressor of tissue plasminogen activator expression.
Pham NL; Franzen A; Levin EG
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):982-7. PubMed ID: 15044208
[TBL] [Abstract][Full Text] [Related]
10. Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.
Darnell GA; Antalis TM; Rose BR; Suhrbier A
J Virol; 2005 Apr; 79(7):4246-56. PubMed ID: 15767426
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Schuster WA; Medcalf RL; Kruithof EK
Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
[TBL] [Abstract][Full Text] [Related]
12. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
13. Cloning of the 5' regulatory regions and functional characterization of the core promoters of ovine PLAU (u-PA) and SERPIN1 (PAI-1).
Lampidonis AD; Theodorou G; Pecorini C; Rebucci R; Baldi A; Politis I
Gene; 2011 Dec; 489(1):11-20. PubMed ID: 21914465
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-1 gene in HTC rat hepatoma cells: identification of cis-acting regulatory elements.
Bruzdzinski CJ; Johnson MR; Goble CA; Winograd SS; Gelehrter TD
Mol Endocrinol; 1993 Sep; 7(9):1169-77. PubMed ID: 8247019
[TBL] [Abstract][Full Text] [Related]
15. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
[TBL] [Abstract][Full Text] [Related]
16. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
Foca C; Moses EK; Quinn MA; Rice GE
Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a helicase-like transcription factor involved in the expression of the human plasminogen activator inhibitor-1 gene.
Ding H; Descheemaeker K; Marynen P; Nelles L; Carvalho T; Carmo-Fonseca M; Collen D; Belayew A
DNA Cell Biol; 1996 Jun; 15(6):429-42. PubMed ID: 8672239
[TBL] [Abstract][Full Text] [Related]
18. A cell-type specific and enhancer-dependent silencer in the regulation of the expression of the human urokinase plasminogen activator gene.
Cannio R; Rennie PS; Blasi F
Nucleic Acids Res; 1991 May; 19(9):2303-8. PubMed ID: 1710352
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
Imagawa S; Fujii S; Dong J; Furumoto T; Kaneko T; Zaman T; Satoh Y; Tsutsui H; Sobel BE
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2407-13. PubMed ID: 16902162
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53.
Kunz C; Pebler S; Otte J; von der Ahe D
Nucleic Acids Res; 1995 Sep; 23(18):3710-7. PubMed ID: 7479001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
